Literature DB >> 21183303

HRCT findings in the lungs of non-smokers with neurofibromatosis.

Anastasia Oikonomou1, Konstantinos Vadikolias, Theodosios Birbilis, Demosthenes Bouros, Panos Prassopoulos.   

Abstract

PURPOSE: Interstitial lung disease in neurofibromatosis (NF) has been disputed and attributed to smoking-related changes. The aim of this study was to describe HRCT findings in the lungs of non-smokers with NF.
MATERIALS AND METHODS: Six never-smokers with NF underwent lung HRCT. Two radiologists evaluated the HRCT scans and a final decision was reached by consensus. The HRCT scans were analyzed with regard to the number, size, location (upper, middle or lower lung zone) and distribution (peripheral and central) of lung cysts and the presence of ground-glass density centrilobular micronodules.
RESULTS: All patients with NF had small (2-18 mm) thin wall cysts and upper-lobe predominant patchy areas of ground-glass density centrilobular micronodules. In five cases, there were 3-17 cysts and in one there were numerous (>100). Lung cysts were central (1), subpleural (1) and in both locations (4).
CONCLUSION: Interstitial lung disease in NF is not associated with smoking and may be entirely asymptomatic. HRCT may reveal small cysts, with barely perceptible walls therefore not representing emphysema and occasionally a minimal micronodular pattern of ground glass opacity. There was no radiologic evidence of lung fibrosis, honeycombing or severe bullous disease.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21183303     DOI: 10.1016/j.ejrad.2010.11.033

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Neurofibromatosis type 1.

Authors:  Alexandre Dias Mançano
Journal:  Radiol Bras       Date:  2022 Jan-Feb

2.  Severe dyspnea in a patient with neurofibromatosis type 1.

Authors:  P B Poble; J C Dalphin; B Degano
Journal:  Respir Med Case Rep       Date:  2017-06-17

3.  Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1.

Authors:  Daniela Rodrigues; Hugo Oliveira; Carina Andrade; Luísa Carvalho; Susana Guimarães; Conceição Souto Moura; Ana Paula Vaz
Journal:  Respir Med Case Rep       Date:  2018-03-17

4.  Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT).

Authors:  Maxim Avanesov; Lennart Well; Azien Laqmani; Thorsten Derlin; Vincent M Riccardi; Gerhard Adam; Victor-Felix Mautner; Johannes Salamon
Journal:  Orphanet J Rare Dis       Date:  2021-01-14       Impact factor: 4.123

Review 5.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

6.  Neurofibromatosis type 1: evaluation by chest computed tomography.

Authors:  Sérgio Ferreira Alves Júnior; Klaus Loureiro Irion; Alessandro Severo Alves de Melo; Gustavo de Souza Portes Meirelles; Rosana Souza Rodrigues; Arthur Soares Souza; Bruno Hochhegger; Gláucia Zanetti; Edson Marchiori
Journal:  Radiol Bras       Date:  2021 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.